Skip to main content
. 2014 Mar 25;92(6):521–526. doi: 10.1111/ejh.12270

Figure 1.

Figure 1

Starting doses in the THALASSA extension study *Wait until LIC>5 mg Fe/g dw and then restart at 5 mg/kg/d if 5 mg/kg/d was effective before interruption or at 10 mg/kg/d if 10–20 mg/kg/d was effective before interruption. With kind permission from Springer Science+Business Media: Ann Hematol, Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-yr extension results from the THALASSA study, 92, 2013, AT Taher, JB Porter, V Viprakasit, A Kattamis, S Chuncharunee, P Sutcharitchan, N Siritanaratkul, R Galanello, Z Karakas, T Lawniczek, D Habr, J Ros, Z Zhu, and MD Cappellini, 1485–1493, Figure 1.